This new antibody may stop one of the deadliest breast cancers

Triple-negative breast cancer (TNBC) is among the most aggressive forms of breast cancer and is especially difficult to treat. It grows rapidly, spreads early, and lacks the hormone receptors that allow many other breast cancers to be treated with targeted drugs. While some patients initially…

Click here to view the original article.